Loading
IARC estimates 10,718 new cancer cases and 5,468 cancer deaths in Armenia in 2024; the commonest new cancers are breast, trachea, bronchus and lung and colorectum. This page is assembled automatically from OnCo's data: 2 trials with a site there and 1 institution, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Breast | 1,590 | 55.6 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Trachea, bronchus and lung | 1,513 | 29.7 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Colorectum | 1,079 | 20.2 | Colorectal cancer |
| Prostate | 878 | 43.1 | Prostate cancer |
| Liver and intrahepatic bile ducts | 581 | 11.3 | Hepatocellular carcinoma |
| Thyroid | 530 | 11.9 | Thyroid cancer |
| Stomach | 504 | 9.8 | Gastric & gastro-oesophageal junction cancer |
| Corpus uteri | 487 | 16.5 | Endometrial cancer |
| Pancreas | 400 | 7.6 | Pancreatic ductal adenocarcinoma |
| Bladder | 399 | 7.2 | Bladder & urothelial cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Trachea, bronchus and lung | 1,270 | 24.5 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Colorectum | 514 | 9.4 | Colorectal cancer |
| Liver and intrahepatic bile ducts | 510 | 9.7 | Hepatocellular carcinoma |
| Breast | 458 | 15.5 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Pancreas | 393 | 7.4 | Pancreatic ductal adenocarcinoma |
| Stomach | 379 | 7.2 | Gastric & gastro-oesophageal junction cancer |
| Prostate | 221 | 10.8 | Prostate cancer |
| Brain, central nervous system | 201 | 4.6 | Glioma & glioblastoma |
| Bladder | 158 | 2.8 | Bladder & urothelial cancer |
| Corpus uteri | 129 | 4.1 | Endometrial cancer |
| Trial | Lead sponsor | ||||
|---|---|---|---|---|---|
| Phase 3 | Active not recruiting | mAbxience Research S.L. | 173 | 2026-09-10 | |
| Phase 3 | Active not recruiting | Servier Affaires Médicales | 84 | 2026-07-31 |
Trial records in OnCo whose ClinicalTrials.gov entry lists at least one site in Armenia, captured 2026-10-07 to 2026-10-07. Recruiting first, then the most recently updated. The status is the study's overall status; whether a site in Armenia is open is on the registry page, under Contacts and Locations.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Armenia is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Armenia is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.